| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -16.4M | 100% | $4.91 | -$80.5M |
| Net | -6 | -16.4M | -100% | -$80.5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kynam Capital Management, LP | 10%+ Owner | $61.3M | Aug 10, 2023 | ||
| Casdin Capital, LLC | Director | $12.9M | Jun 10, 2024 | ||
| William D. Baird III | President and CEO, Director | $6.24M | -$120K | -1.89% | Mar 17, 2025 |
| Nick Leschly | Director | $5.43M | -$255K | -4.49% | Jan 3, 2025 |
| Victoria Eatwell | Chief Financial Officer | $2.48M | -$26.8K | -1.07% | Mar 17, 2025 |
| Philip D. Gregory | Chief Scientific Officer | $1.79M | Jan 5, 2024 | ||
| Jessica Snow | Chief Operating Officer | $1.54M | -$63.7K | -3.98% | Mar 17, 2025 |
| Nicola Heffron | Chief Operating Officer | $669K | Feb 7, 2023 | ||
| Wei Lin | Director | $232K | Jun 10, 2024 | ||
| Denice Torres | Director | $227K | Jun 10, 2024 | ||
| Sarah Glickman | Director | $210K | Jun 10, 2024 | ||
| Marcela V. Maus | Director | $175K | -$13.2K | -7.01% | Nov 18, 2024 |
| Daniel Lynch | Director | $145K | Jun 13, 2023 | ||
| Charles W. Newton | Director | $142K | Jun 10, 2024 | ||
| Ramy Ibrahim | Director | $138K | Jun 13, 2023 | ||
| William R. Sellers | Director | $24.7K | Nov 11, 2021 | ||
| Kynam Global Healthcare Master Fund, LP | 10%+ Owner | $0 | -$80.1M | -100% | Mar 11, 2025 |
| bluebird bio, Inc. | 10%+ Owner | Nov 3, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|